What move does the options market price into Krystal Biotech's report?

Implied ±15.8%, either direction · provisional.

How often does Krystal Biotech move more than the options market prices?

4 of the last 8 reports moved at least as far as the implied move.

KRYSNasdaqBiological Products, (No Diagnostic Substances)

Krystal Biotech, Inc. (KRYS) earnings date, market-implied expected move, and options open interest by expiry

301.49

−9.35 · −3.01%

post 301.49 0.00%

After hours16:00 ETdelayed

Open310.29Volume414,444Mkt cap$9.2BP/E39.36EPS7.66

Day301.20 – 311.543%52-wk192.52 – 382.5457%

KRYS

Krystal Biotech, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±15.8%implied · straddle

261.63360.05

spot 310.84exp Feb 19ATM strike 310ATM straddle 57.90IV 43%

Nov 4 closeprovisional

Expected move

Inputs

Next report

Feb 16

before open · in 103 days

est.Q4 FY26

Calendar

Next report

Last report

−10.95%

vs ±8.7% implied · ×1.26

shaded = implied · ▲▼ = realized

Nov 2 '26 · confirmed

Implied vs realized

Largest filed tie

—

13F top-10 QoQ

+5.69%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

423 managers

Top fund weight

1.10%

KRYS weight · XBI

N-PORTJun 30 '26

5 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Krystal Biotech (KRYS) is expected to report on Feb 16 before open (estimated date).

Implied vs realized

8 reports

4 of 8≥ implied

avg implied: ±9.0%
avg realized: ±7.4%

Nov 4 '24Nov 4 '24confirmed±11.9%▼−3.14%×0.26

May 6 '25May 6 '25confirmed±9.3%▼−14.06%×1.51

Aug 4 '25Aug 4 '25confirmed±9.3%▼−14.04%×1.51

Nov 3 '25Nov 3 '25confirmed±11.1%▲+0.17%×0.02

Jan 12 '26Jan 12 '26confirmed±3.8%▲+4.10%×1.07

Q1 FY26Feb 17 '26confirmed±8.1%▲+4.12%×0.51

Q2 FY26Aug 3 '26confirmed±10.1%▼−8.37%×0.83

Q3 FY26Nov 2 '26confirmed±8.7%▼−10.95%×1.26

quarterimplied−15%0+15%realized×

Q3 FY26±8.7%▼−10.95%×1.26

Q2 FY26±10.1%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 4 close

4.87OI · 4 expiries · Nov 4 closeP/C open interest · Feb 19 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

5380%Nov 2015d0.281,890+1%0.28

203+3%Dec 1843d0.95213−1%0.95

report · Feb 16 · before open · est.

1,046+1%Feb 19106d215+1%

9250%Mar 19134d2.543640%2.54

ExpiryPutsCallsP/C

Nov 2015d5380%1,890+1%0.28

Dec 1843d203+3%213−1%0.95

report · Feb 16 · before open · est.

Feb 19106d1,046+1%

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±15.8%

Funds 4

XBI±0.2%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod 1 more fund Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ3 FY26

49.53%as filednet margin · revenue +6.81% QoQ · +30.21% YoY

Revenue

$127M+6.81% QoQ

Gross profit

$120M+6.21% QoQ

94.07% margin

Operating income

$71M+21.79% QoQ

55.87% margin

Pre-tax income

$80M+21.29% QoQ

Net income

$63M+15.15% QoQ

49.53% margin

Cost of revenue

$8M+17.38% QoQ

Operating expenses

$49M−10.54% QoQ

SG&A $34M

R&D $15M

Tax

$17M+50.98% QoQ

Other income

$9M+17.46% QoQ

Revenue$127M+6.81%

Gross profit

$120M+6.21%

94.07% margin

Operating income

$71M+21.79%

55.87% margin

Pre-tax income

$80M+21.29%

Net income

$63M+15.15%

49.53% margin

Cost of revenue

$8M+17.38%

Operating expenses

$49M−10.54%

SG&A $34M

R&D $15M

Other income$9M+17.46%

Tax$17M+50.98%

flow · deduction · inflow · signed % = QoQSource: SEC filings · standardized · QE Sep 30 '26 · width = $

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 4 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

CPI ×1.18· ±2.4% vs ±2.1% · 11 releases

eventrelease day|move|up · n×base

CPIconsumer prices±2.4%7 of 11×1.18

FOMCrate decision±2.4%12 of 24×1.14

NFPjobs report±2.2%5 of 10×1.07

PCEpersonal income & outlays±1.7%14 of 20×0.83

CPROFcorporate profits±1.5%8 of 12×0.73

GDPgross domestic product±1.2%12 of 20×0.58

PPIproducer prices±1.1%4 of 11×0.56

Bar = avg |move| to ±3% · tick = ±2.1% avg day · ×base = |move| ÷ ±2.1% · min 6 releases

Earnings history

EPS 2.05 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	Nov 2 '26 · confirmed	2.05	—
Q2 FY26	Aug 3 '26 · confirmed	1.79	—
Q1 FY26	Feb 17 '26 · confirmed	1.83	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod